Orbimed Capital GP III LLC
SEC-identified person · CIK 1432241 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Viewray, Inc. VRAY | Director | filed 2016 - 2018 |
| Pieris Pharmaceuticals, INC. PVLA | Director | filed 2015 - 2018 |
| Glaukos Corp GKOS | Director | filed 2015 - 2018 |
| Roka Bioscience, Inc. ROKA | Director | filed 2014 - 2017 |
| Response Biomedical Corp RBM | Director | filed 2012 - 2016 |
| Selecta Biosciences INC SELB | Director | filed 2016 - 2016 |
| Sientra, Inc. SIEN | Officer | filed 2014 - 2015 |
| Ambit Biosciences Corp AMBI | Officer | filed 2013 - 2013 |
| Amarin Corp PLC\UK AMRN | Director | filed 2011 - 2012 |
| Complete Genomics INC GNOM | Officer | filed 2010 - 2012 |
| Pacira Pharmaceuticals, Inc. PCRX | Officer | filed 2011 - 2012 |
| Bthc VI Inc NA | Officer | filed 2011 - 2011 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.